Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)4 passages
• 22q11.2 deletion status and disease burden in children and adolescents with tetralogy of Fallot.1 passage
• A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.1 passage
• Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization.1 passage
• Admixture Mapping of Subclinical Atherosclerosis and Subsequent Clinical Events Among African Americans in 2 Large Cohort Studies.1 passage
• Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.1 passage
• Alternative Splicing, Internal Promoter, Nonsense-Mediated Decay, or All Three: Explaining the Distribution of Truncation Variants in Titin.1 passage
• Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.1 passage
• Analysis of 60 706 Exomes Questions the Role of De Novo Variants Previously Implicated in Cardiac Disease.1 passage
• Aortic Disease Presentation and Outcome Associated With ACTA2 Mutations.1 passage
• Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults.1 passage
• Applying High-Resolution Variant Classification to Cardiac Arrhythmogenic Gene Testing in a Demographically Diverse Cohort of Sudden Unexplained Deaths.1 passage
• Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.1 passage
• Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis.1 passage
• Association of Exome Sequences With Cardiovascular Traits Among Blacks in the Jackson Heart Study.1 passage
• Association of Rare Loss-Of-Function Alleles in HAL, Serum Histidine: Levels and Incident Coronary Heart Disease.1 passage
• Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study.1 passage
• Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study.1 passage
• Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry.1 passage
• Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome.1 passage
• Body Height and Incident Risk of Venous Thromboembolism: A Cosibling Design.1 passage
• Burden of Recurrent and Ancestral Mutations in Families With Hypertrophic Cardiomyopathy.1 passage
• Calcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve Disease.1 passage
• Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.1 passage
• Cardiovascular Risk Factors and Ischemic Heart Disease: Is the Confluence of Risk Factors Greater Than the Parts? A Genetic Approach.1 passage
• Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation.1 passage
• Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels.1 passage
• Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.1 passage
• Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a1 passage
• Chasing-and Catching-the Wild Goose: Hypothesis-Free Post-Hoc Stratification Studies as a New Paradigm for Drug Development.1 passage
• Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites.1 passage
• Circulating cholesteryl ester transfer protein and coronary heart disease: mendelian randomization meta-analysis.1 passage
• Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.1 passage
• Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.1 passage
• Clinical Utility of Multimarker Genetic Risk Scores for Prediction of Incident Coronary Heart Disease: A Cohort Study Among Over 51 000 Individuals of European Ancestry.1 passage
• Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study.1 passage
• Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.1 passage
• Commercially Available Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Another Piece in Our Tool Box, but Not a Swiss Army Knife Yet.1 passage
• Common and Rare Genetic Variation in CCR2, CCR5, or CX3CR1 and Risk of Atherosclerotic Coronary Heart Disease and Glucometabolic Traits.1 passage
• Common and rare variants in SCN10A modulate the risk of atrial fibrillation.1 passage
• Common low-density lipoprotein receptor p.G116S variant has a large effect on plasma low-density lipoprotein cholesterol in circumpolar inuit populations.1 passage
• Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.1 passage
• Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.1 passage
• DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis.1 passage
• DNA methylation of lipid-related genes affects blood lipid levels.1 passage
• Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery.1 passage
• Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile Using Historical Data.1 passage
• Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.1 passage
• Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.1 passage
• Diminished1 passage
• Do Genetic Factors Modify the Relationship Between Obesity and Hypertriglyceridemia? Findings From the GLACIER and the MDC Studies.1 passage
• Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics.1 passage
• Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis.1 passage
• Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).1 passage
• Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.1 passage
• Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium.1 passage
• Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease.1 passage
• Endothelial Cell Bioenergetics and Mitochondrial DNA Damage Differ in Humans Having African or West Eurasian Maternal Ancestry.1 passage
• Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.1 passage
• Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association.1 passage
• Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.1 passage
• Epigenetic Signatures of Cigarette Smoking.1 passage
• Examining rare and low-frequency genetic variants previously associated with lone or familial forms of atrial fibrillation in an electronic medical record system: a cautionary note.1 passage
• Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.1 passage
• Exome sequencing in suspected monogenic dyslipidemias.1 passage
• Expression quantitative trait Loci acting across multiple tissues are enriched in inherited risk for coronary artery disease.1 passage
• Eya4 Induces Hypertrophy via Regulation of p27kip1.1 passage
• Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes.1 passage
• Familial Aggregation of Aortic Valvular Stenosis: A Nationwide Study of Sibling Risk.1 passage
• Familial Analysis of Epistatic and Sex-Dependent Association of Genes of the Renin-Angiotensin-Aldosterone System and Blood Pressure.1 passage
• Familial Ebstein Anomaly: Whole Exome Sequencing Identifies Novel Phenotype Associated With1 passage
• Fifteen Genetic Loci Associated With the Electrocardiographic P Wave.1 passage
• Functional Analysis of a Carotid Intima-Media Thickness Locus Implicates BCAR1 and Suggests a Causal Variant.1 passage
• Functional Genomics Analysis of Big Data Identifies Novel Peroxisome Proliferator-Activated Receptor γ Target Single Nucleotide Polymorphisms Showing Association With Cardiometabolic Outcomes.1 passage
• Functional Polymorphism rs13306560 of the MTHFR Gene Is Associated With Essential Hypertension in a Mexican-Mestizo Population.1 passage
• Functional Validation of a Common Nonsynonymous Coding Variant in ZC3HC1 Associated With Protection From Coronary Artery Disease.1 passage
• Gene-Based Risk Stratification for Cardiac Disorders in1 passage
• Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.1 passage
• Genetic Insurance Discrimination in Sudden Arrhythmia Death Syndromes: Empirical Evidence From a Cross-Sectional Survey in North America.1 passage
• Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?1 passage
• Genetic Risk Scores Predict Recurrence of Acute Coronary Syndrome.1 passage
• Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.1 passage
• Genetic Testing in Pediatric Left Ventricular Noncompaction.1 passage
• Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry).1 passage
• Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis.1 passage
• Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities.1 passage
• Genetic Variations in MicroRNA-Binding Sites Affect MicroRNA-Mediated Regulation of Several Genes Associated With Cardio-metabolic Phenotypes.1 passage
• Genetic evidence for PLASMINOGEN as a shared genetic risk factor of coronary artery disease and periodontitis.1 passage
• Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects.1 passage
• Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.1 passage
• Genome-Wide Association Study Meta-Analysis of Long-Term Average Blood Pressure in East Asians.1 passage
• Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the1 passage
• Genome-Wide Gene-Potassium Interaction Analyses on Blood Pressure: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity).1 passage
• Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.1 passage
• Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study.1 passage
• Genome-wide association study for endothelial growth factors.1 passage
• Genome-wide meta-analyses of plasma renin activity and concentration reveal association with the kininogen 1 and prekallikrein genes.1 passage
• Genomic Triangulation and Coverage Analysis in Whole-Exome Sequencing-Based Molecular Autopsies.1 passage
• Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes.1 passage
• Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).1 passage
• Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams-Oliver Syndrome With Variable Cardiac Anomalies.1 passage
• Heritability of Atrial Fibrillation.1 passage
• Heritability of Mitral Regurgitation: Observations From the Framingham Heart Study and Swedish Population.1 passage
• Heritability of the Severity of the Metabolic Syndrome in Whites and Blacks in 3 Large Cohorts.1 passage
• Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.1 passage
• Human Connexin43E42K mutation from a sudden infant death victim leads to impaired ventricular activation and neonatal death in mice.1 passage
• Identification of Cadherin 2 (1 passage
• Identity-by-Descent Mapping Identifies Major Locus for Serum Triglycerides in Amerindians Largely Explained by an1 passage
• Impact of Selection Bias on Estimation of Subsequent Event Risk.1 passage
• In Silico Post Genome-Wide Association Studies Analysis of C-Reactive Protein Loci Suggests an Important Role for Interferons.1 passage
• In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.1 passage
• Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.1 passage
• Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.1 passage
• Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism: Pooled Analysis of Four Family Cohort Studies.1 passage
• Interaction of Insulin Resistance and Related Genetic Variants With Triglyceride-Associated Genetic Variants.1 passage
• Interactions of Lipid Genetic Risk Scores With Estimates of Metabolic Health in a Danish Population.1 passage
• International Genome-Wide Association Study Consortium Identifies Novel Loci Associated With Blood Pressure in Children and Adolescents.1 passage
• International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC (Montalcino Aortic Consortium).1 passage
• Investigating the Genetic Architecture of the PR Interval Using Clinical Phenotypes.1 passage
• Investigating the Genetic Causes of Sudden Unexpected Death in Children Through Targeted Next-Generation Sequencing Analysis.1 passage
• Letter by Finsterer and Zarrouk-Mahjoub Regarding Article, "Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction".1 passage
• Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.1 passage
• Loss of Function Mutations in NNT Are Associated With Left Ventricular Noncompaction.1 passage
• Loss of Y Chromosome in Blood Is Associated With Major Cardiovascular Events During Follow-Up in Men After Carotid Endarterectomy.1 passage
• Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice.1 passage
• Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease.1 passage
• Merging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association.1 passage
• Metabolic Characterization of a Rare Genetic Variation Within APOC3 and Its Lipoprotein Lipase-Independent Effects.1 passage
• Metabolic Profiling of Adiponectin Levels in Adults: Mendelian Randomization Analysis.1 passage
• Methylenetetrahydrofolate Dehydrogenase 1 Polymorphisms Modify the Associations of Plasma Glycine and Serine With Risk of Acute Myocardial Infarction in Patients With Stable Angina Pectoris in WENBIT (Western Norway B Vitamin Intervention Trial).1 passage
• MicroRNA Signature of Cigarette Smoking and Evidence for a Putative Causal Role of MicroRNAs in Smoking-Related Inflammation and Target Organ Damage.1 passage
• MicroRNA-150 protects the heart from injury by inhibiting monocyte accumulation in a mouse model of acute myocardial infarction.1 passage
• Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels.1 passage
• Multiancestry Study of Gene-Lifestyle Interactions for Cardiovascular Traits in 610 475 Individuals From 124 Cohorts: Design and Rationale.1 passage
• Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis.1 passage
• Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI.1 passage
• Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing.1 passage
• NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).1 passage
• New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals.1 passage
• Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.1 passage
• Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.1 passage
• Novel 6p21.3 Risk Haplotype Predisposes to Acute Coronary Syndrome.1 passage
• Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function.1 passage
• Novel Genetic Loci Associated With Retinal Microvascular Diameter.1 passage
• Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction.1 passage
• Novel Mutation in1 passage
• Novel Variant in the1 passage
• Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.1 passage
• Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.1 passage
• PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk.1 passage
• Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials.1 passage
• Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib.1 passage
• Plasma Proteomics for Epidemiology: Increasing Throughput With Standard-Flow Rates.1 passage
• Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.1 passage
• Predicting the Functional Impact of KCNQ1 Variants of Unknown Significance.1 passage
• Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.1 passage
• Prediction of Adult Dyslipidemia Using Genetic and Childhood Clinical Risk Factors: The Cardiovascular Risk in Young Finns Study.1 passage
• Prediction of Adulthood Obesity Using Genetic and Childhood Clinical Risk Factors in the Cardiovascular Risk in Young Finns Study.1 passage
• Prevalence and Clinical Implication of Double Mutations in Hypertrophic Cardiomyopathy: Revisiting the Gene-Dose Effect.1 passage
• Pro12Ala polymorphism of the PPARγ2 gene interacts with a mediterranean diet to prevent telomere shortening in the PREDIMED-NAVARRA randomized trial.1 passage
• Proteomic Analysis of Human Pluripotent Stem Cell-Derived, Fetal, and Adult Ventricular Cardiomyocytes Reveals Pathways Crucial for Cardiac Metabolism and Maturation.1 passage
• Quantitative Proteome Analysis Reveals Increased Content of Basement Membrane Proteins in Arteries From Patients With Type 2 Diabetes Mellitus and Lower Levels Among Metformin Users.1 passage
• Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics.1 passage
• RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol.1 passage
• Rare Exome Sequence Variants in CLCN6 Reduce Blood Pressure Levels and Hypertension Risk.1 passage
• Rare Variants in the ADAMTS13 Von Willebrand Factor-Binding Domain Contribute to Pediatric Stroke.1 passage
• Recessive MYH6 Mutations in Hypoplastic Left Heart With Reduced Ejection Fraction.1 passage
• Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?"1 passage
• SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).1 passage
• Screening of the1 passage
• Search for Rare Copy-Number Variants in Congenital Heart Defects Identifies Novel Candidate Genes and a Potential Role for FOXC1 in Patients With Coarctation of the Aorta.1 passage
• Searching for the Causal Variants of the Association Between Hypertriglyceridemia and the Genome-Wide Association Studies-Derived Signals? Take a Look in the Native American Populations.1 passage
• Serum lipid levels, body mass index, and their role in coronary artery calcification: a polygenic analysis.1 passage
• Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular events.1 passage
• Socioeconomic Status Interacts with the Genetic Effect of a Chromosome 9p21.3 Common Variant to Influence Coronary Artery Calcification and Incident Coronary Events in the Heinz Nixdorf Recall Study (Risk Factors, Evaluation of Coronary Calcium, and Lifestyle).1 passage
• Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.1 passage
• Statin Effects on Metabolic Profiles: Data From the PREVEND IT (Prevention of Renal and Vascular End-stage Disease Intervention Trial).1 passage
• Sudden Cardiac Arrest and Rare Genetic Variants in the Community.1 passage
• Superoxide Dismutase 1 In Vivo Ameliorates Maternal Diabetes Mellitus-Induced Apoptosis and Heart Defects Through Restoration of Impaired Wnt Signaling.1 passage
• Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course.1 passage
• Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.1 passage
• Systematic Characterization of Long Noncoding RNAs Reveals the Contrasting Coordination of Cis- and Trans-Molecular Regulation in Human Fetal and Adult Hearts.1 passage
• Targeted deep sequencing reveals no definitive evidence for somatic mosaicism in atrial fibrillation.1 passage
• Technical Advances for the Clinical Genomic Evaluation of Sudden Cardiac Death: Verification of Next-Generation Sequencing Panels for Hereditary Cardiovascular Conditions Using Formalin-Fixed Paraffin-Embedded Tissues and Dried Blood Spots.1 passage
• The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.1 passage
• The Influence of Known Genetic Variants on Subclinical Cardiovascular Outcomes in Childhood: Generation R Study.1 passage
• The Long Noncoding RNA Landscape of the Ischemic Human Left Ventricle.1 passage
• Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.1 passage
• Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.1 passage
• Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.1 passage
• Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.1 passage
• Validation of Polygenic Scores for QT Interval in Clinical Populations.1 passage
• Variable transcriptional regulation of the human aldosterone synthase gene causes salt-dependent high blood pressure in transgenic mice.1 passage
• Variants for HDL-C, LDL-C, and triglycerides identified from admixture mapping and fine-mapping analysis in African American families.1 passage
• Whole Exome Sequencing Identifies Truncating Variants in Nuclear Envelope Genes in Patients With Cardiovascular Disease.1 passage
• Whole-Exome Molecular Autopsy After Exertion-Related Sudden Unexplained Death in the Young.1 passage
• ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure.1 passage
• α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.1 passage